Gluessel- UofC iGEM 1, Calgary, AB

Novel treatment of diabetes through the use of intestinal proteins

“The prevalence of diabetes in the lowest income group are 2.1 times higher than other demographic. With the growing concerns over economic and health stress, it is imperative to provide the community with accessible, sustainable, and cost-effective personal health management tools.

Gluessel offers an innovative approach that combines recombinant mussel adhesive protein and microneedle technology to create a minimally invasive and budget-friendly glucose monitor. By reducing inequality and promoting well-being, this technology can help improve the overall health of the community.”